#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodevelopmental disorder Lupus nephritis Astrocytoma Sexually transmitted disease Extra-osseous Ewing's sarcoma Neutropenia Central nervous system neoplasm Ocular lymphoma Metachromatic leukodystrophy Chronic lymphocytic leukaemia refractory Erythema Breast cancer metastatic Parkinson's disease Haemophilia B with anti factor IX Glycogen storage disease type V More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Diagnostics Mantle cell lymphoma – Diagnostics Nodal marginal zone B-cell lymphoma – Life with Disease Mantle cell lymphoma stage III – Life with Disease Immunodeficiency congenital Choroid melanoma – Diagnostics Pleural mesothelioma malignant – Life with Disease Urea cycle disorder – Trials in Disease Alveolar rhabdomyosarcoma – Diagnostics Prolymphocytic leukaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludarabine Phosphate Ph. Eur. Meropenem Trihydrate Olodaterol Icatibant GRNA-001 AGANIRSEN Alx148 X-396 Padeliporfin Acemetacin Foscarnet Sodium Hexahydrate Agrostis Stolonifera Pollen Gremubamab Terlipressin Sirolimus Codeine Phosphate Doravirine Taxanes Aripiprazole AZD0120 More therapies…

    Learn about Your Condition

    Pericarditis High-grade B-cell lymphoma Prostatitis Escherichia coli Macular degeneration Appendicitis Cerebral palsy Rhabdoid tumour of the kidney Respiratory distress Vasoplegia syndrome Muscular dystrophy Pouchitis Mitral valve disease Cervix carcinoma stage II Angiosarcoma Fibromyalgia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Zipalertinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Greece Italy The Netherlands +3

  • Comparison of compression therapy alone versus compression therapy with phenoxymethylpenicillin for preventing recurrent erysipelas in lower limbs

    Not yet recruiting

    3 1 1 1
    France

  • Study comparing low-dose versus standard-dose epinephrine for better brain recovery in patients with out-of-hospital cardiac arrest

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Epinephrine Bitartrate
    France

  • Study of Anakinra compared to placebo for treating acute myocarditis in children admitted to intensive care units

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Anakinra
    • Sodium Chloride
    France

  • Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Panitumumab
    • Sotorasib
    • Fluorouracil
    France Germany Italy Spain

  • Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +3

  • Evaluation of Methylprednisolone and Prednisone in Adult Patients with Acute Myocarditis and Reduced Heart Function

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone
    • Prednisone
    France

  • Study on Stopping Allopurinol or Febuxostat in Gout Patients in Remission

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Allopurinol
    • Febuxostat
    France

  • Study on Etoposide for Patients with Severe Hemophagocytic Lymphohistiocytosis in Intensive Care

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Etoposide
    France

  • Study of Levosimendan Before Tricuspid Valve Surgery in Patients with Right Ventricular Dysfunction

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Levosimendan
    France
Previous Page
1 … 24 25 26 27 28 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!